Literature DB >> 11517382

Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus.

J E Libbey1, I J McCright, I Tsunoda, Y Wada, R S Fujinami.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) belongs the family Picornaviridae. TMEV not only replicates in the gastrointestinal tract but also spreads to the central nervous system (CNS) either by a hematogenous or a neural pathway during natural infection. The DA strain of TMEV infects neurons during the acute phase, and glial cells and macrophages during the chronic phase, leading to a demyelinating disease similar to multiple sclerosis. Different virus-host receptor interactions in the peripheral and the neuronal cells could explain the pathways of viral spread from the peripheral to the CNS and neurons to glial cells. However, the receptor for TMEV remains unknown. P0 protein, a 28-31 kD glycoprotein, belongs to the immunoglobulin superfamily and constitutes 50% of the total myelin protein in the peripheral nerve. Other picornaviruses use members of the immunoglobulin superfamily as receptors. Thus we hypothesized P0 protein could act as a receptor for TMEV. In a virus overlay assay, radiolabeled TMEV bound to a 28-30 kD protein from the peripheral nerve of wild-type C57BL/6, but no binding was found in the peripheral nerve from P0-knockout mice. TMEV replicated fourfold higher in P0-transfected BW5147.G.1.4 cells than in mock-transfected cells. The increase in virus replication in the P0-transfected cell line was blocked by preincubation of the cells with anti-P0 antibody. A virus binding study showed that TMEV bound to P0-transfected cells but not to mock-transfected cells. The use of the P0 protein in Schwann cells as a receptor may be one mechanism by which TMEV spreads from the gastrointestinal tract to the CNS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517382     DOI: 10.1080/13550280152058753

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  45 in total

1.  The GDVII strain of Theiler's virus spreads via axonal transport.

Authors:  C Martinat; N Jarousse; M C Prévost; M Brahic
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  Myelin P0-protein, more than just a structural protein?

Authors:  M T Filbin; G I Tennekoon
Journal:  Bioessays       Date:  1992-08       Impact factor: 4.345

3.  Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides: correlation of the polypeptide profile with virulence.

Authors:  H L Lipton; A Friedmann
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

Review 4.  Early events in poliovirus infection: virus-receptor interactions.

Authors:  V R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.

Authors:  Y Wada; M L Pierce; R S Fujinami
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

6.  Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation.

Authors:  R S Fujinami; M B Oldstone
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Multiple regulatory elements control transcription of the peripheral myelin protein zero gene.

Authors:  A M Brown; G Lemke
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

8.  Three-dimensional structure of Theiler virus.

Authors:  R A Grant; D J Filman; R S Fujinami; J P Icenogle; J M Hogle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  ENCEPHALOMYELITIS OF MICE : III. EPIDEMIOLOGY.

Authors:  M Theiler; S Gard
Journal:  J Exp Med       Date:  1940-06-30       Impact factor: 14.307

10.  SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE.

Authors:  M Theiler
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

View more
  5 in total

1.  Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis.

Authors:  Honey V Reddi; A S Manoj Kumar; Aisha Y Kung; Patricia D Kallio; Brian P Schlitt; Howard L Lipton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination.

Authors:  Kristen M Drescher; Steven M Tracy
Journal:  Virology       Date:  2006-10-09       Impact factor: 3.616

3.  Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.

Authors:  Ingeborg J McCright; Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

4.  Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses.

Authors:  Honey V Reddi; Howard L Lipton
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 5.  Viral mouse models used to study multiple sclerosis: past and present.

Authors:  J E Libbey; R S Fujinami
Journal:  Arch Virol       Date:  2021-02-13       Impact factor: 2.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.